UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
SunCoke Energy
SXC
$797M
| $474K | ﹤0.01% |
48,340
-41,452
| -46% | -$428K |
|
|
AUTL
5027
Autolus Therapeutics
AUTL
$562M
| $473K | ﹤0.01% |
135,791
+42,943
| +46% | +$185K |
|
5028
Metallus
MTUS
$898M
| $472K | ﹤0.01% |
23,309
-27,835
| -54% | -$609K |
|
|
UNIT
5029
Uniti Group
UNIT
$2.32B
| $472K | ﹤0.01% |
161,783
-162,211
| -50% | -$680K |
|
5030
Center Bancorp
CNOB
$1.78B
| $472K | ﹤0.01% |
25,004
-36,390
| -59% | -$684K |
|
|
OEFA
5031
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$37.7M
| $472K | ﹤0.01% |
15,592
-500
| -3% | -$15K |
|
5032
Great Southern Bancorp
GSBC
$878M
| $472K | ﹤0.01% |
8,480
-5,844
| -41% | -$306K |
|
5033
Enliven Therapeutics
ELVN
$4.43B
| $470K | ﹤0.01% |
20,118
-6,717
| -25% | -$141K |
|
5034
Riskified
RSKD
$716M
| $470K | ﹤0.01% |
73,523
+59,105
| +410% | +$334K |
|
5035
SI-BONE Inc
SIBN
$834M
| $469K | ﹤0.01% |
36,308
-32,183
| -47% | -$460K |
|
5036
Pitney Bowes
PBI
$2.39B
| $469K | ﹤0.01% |
92,243
-73,197
| -44% | -$350K |
|
5037
Century Communities
CCS
$2.03B
| $468K | ﹤0.01% |
5,735
-12,302
| -68% | -$1.03M |
|
|
FFIC
5038
DELISTED
Flushing Financial
FFIC
| $467K | ﹤0.01% |
35,486
-9,070
| -20% | -$111K |
|
5039
Galicia Financial Group
GGAL
$7.42B
| $467K | ﹤0.01% |
15,268
+12,872
| +537% | +$413K |
|
5040
Syntax Stratified US Total Market Hedged ETF
SHUS
$25.3M
| $466K | ﹤0.01% |
11,543
+11,057
| +2,275% | +$451K |
|
5041
iShares Asia/Pacific Dividend ETF
DVYA
$72.2M
| $466K | ﹤0.01% |
13,273
-1,375
| -9% | -$50.3K |
|
5042
State Street Global Allocation ETF
GAL
$315M
| $465K | ﹤0.01% |
10,764
+3,114
| +41% | +$134K |
|
|
AAMI
5043
Acadian Asset Management
AAMI
$3.19B
| $465K | ﹤0.01% |
20,986
-18,055
| -46% | -$408K |
|
5044
PUT
Novavax
NVAX
$1.31B
| $465K | ﹤0.01% |
+36,700
| New | +$369K |
|
|
SMC
5045
Summit Midstream
SMC
$419M
| $464K | ﹤0.01% |
+13,043
| New | +$411K |
|
5046
Lipocine
LPCN
$17.6M
| $463K | ﹤0.01% |
56,221
+55,790
| +12,944% | +$349K |
|
5047
Voyager Therapeutics
VYGR
$201M
| $463K | ﹤0.01% |
58,492
-45,792
| -44% | -$384K |
|
5048
Phibro Animal Health
PAHC
$1.39B
| $463K | ﹤0.01% |
27,583
-22,112
| -44% | -$355K |
|
5049
InterContinental Hotels
IHG
$23.2B
| $462K | ﹤0.01% |
4,359
-713
| -14% | -$72.2K |
|
5050
Belpointe PREP
OZ
$183M
| $461K | ﹤0.01% |
7,958
+3,008
| +61% | +$179K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.